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Abstract: Osteoporotic fracture has a major impact upon health, both in terms of acute and 
long term disability and economic cost. Peak bone mass, achieved in early adulthood, is a 
major determinant of osteoporosis risk in later life. Poor early growth predicts reduced 
bone mass, and so risk of fracture in later life. Maternal lifestyle, body build and 25(OH) 
vitamin  D  status  predict  offspring  bone  mass.  Recent  work  has  suggested  epigenetic 
mechanisms as key to these observations. This review will explore the role of the early 
environment in determining later osteoporotic fracture risk. 
Keywords:  osteoporosis; epigenetic; early life origins; fracture; bone mass; vitamin D; 
neonate; fetus 
 
1. The Burden of Osteoporotic Fracture 
Osteoporosis  is  a  skeletal  disorder  characterized  by  low  bone  mass  and  microarchitectural 
deterioration of bone tissue, with a consequent increase in bone fragility [1]. It is the commonest bone 
disorder  in  Western  populations,  and  an  important  public  health  issue  because  of  the  potentially 
devastating consequences of fragility fracture [2]. Hip fractures are the most important consequence of 
osteoporosis; they require hospital admission and are associated with an excess mortality of 10–20% in 
the first year after the fracture [3]. In white women the one in six lifetime risk of hip fracture is greater 
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than the one in nine risk of developing breast cancer [4]. The annual cost of all osteoporotic fractures 
to the United States has been estimated as $20 billion and to the European Union as $30 billion [5]. 
Osteoporotic fracture is a result of a combination of an injury generating a given force, and bone 
strength weak enough to fracture at that force. An established measure of bone strength is bone mass, 
which  is  a  composite  of  bone  size  and  bone  volumetric  mineral  density  [6].  The  DXA  derived 
measurements which contribute to bone mass are thus bone mineral content (BMC, g), bone area (BA, 
cm
2), bone mineral density (BMD, g/cm
2). True volumetric BMD (vBMD, g/cm
3) cannot be directly 
measured by DXA, although estimates can be obtained by adjusting for body size.  
Bone mass appears to track through childhood and adolescence to reach a peak in early adulthood, 
more through an increase of bone size than true volumetric density [7]. It then declines in older age, 
through loss of bone tissue (thinning of trabeculae and cortex), with an accelerated rate of decline at 
the menopause. Prospective studies in adults indicate that the risk of osteoporotic fracture increases 
continuously as BMD declines, with a 1.5–3 fold increase in the risk of osteoporotic fracture for each 
standard deviation fall in BMD [8]. The ability to predict fracture risk from BMD is at least as good, if 
not better, than the ability to predict heart disease from blood cholesterol levels, and stroke from blood 
pressure [9].  
Preventative strategies against osteoporosis can be aimed at either optimizing the peak bone mass 
obtained, or reducing the rate of bone loss. Optimization of peak bone mass may be more amenable to 
public health strategies and has been shown in mathematical models to be a powerful predictor of age 
of onset of osteoporosis [6,10]. Although this crucial characteristic is partly inherited, the currently 
identified genetic markers only explain a small amount of the variation in individual peak bone mass 
and fracture risk [11]. Evidence is accruing that environmental factors may act early in development (in 
utero  and  early  postnatal  life),  interacting  with  the  genome  to  produce  a  persisting  influence  on 
postnatal skeletal development. 
2. Skeletal Development 
In order to understand the impact of environmental factors on osteoporosis risk it is necessary to 
understand fetal bone development. The bones of principal interest in terms of fragility fractures in 
later life are the long bones, which are formed by endochondral ossification. This process requires a 
pre-existing cartilaginous model, which starts to develop at 5 weeks gestation with the migration and 
condensation of mesenchymal cells in areas destined to form the bones [12]. These pre-cartilagenous 
anlagen reflect the size, shape, position and number of skeletal elements that will be present in the 
mature skeleton [13]. The mesenchymal cells then differentiate into chondrocytes, which form the 
cartilage.  As  the  chondrocytes  proliferate  they  produce  an  extracellular  matrix,  which  facilitates 
angiogenesis and invasion of osteoblasts from the perichondrium. The proliferation of the chondrocytes 
has been shown to be influenced by parathyroid hormone related peptide (PTHrp) [14], cytokines of 
the  IGF  axis  [15],  activated  vitamin  D  [16]  and  triodothryronine  [17].  Once  the  osteoblasts  have 
invaded the cartilage they lay down matrix, which is mineralized to form the bones.  
The long bones then undergo a period of rapid cell division in the second trimester [6]; this is a 
―critical period‖ for long bone growth. ―Critical periods‖ are specific periods of rapid cell division, 
which occur at different times during gestation in different tissues [18], for example the kidney has a Int. J. Environ. Res. Public Health 2010, 7                 
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critical period in the weeks immediately before birth. Tissues that are in critical periods are thought to 
be particularly susceptible to an adverse environment, such as a reduction in nutrients. Rickets has 
served as a longstanding example of an adverse early life environment, in the form of vitamin D 
deficiency, disrupting the process of bone development and untreated can lead to persistent changes in 
the child‘s bone structure. It is now being realized that early adverse conditions have the potential to 
form ―memory‖ which influences the risk of disease in adulthood too [19].  
We will discuss the evidence for the impact of maternal behavior upon bone development, using six 
groups of studies: (1) retrospective cohort studies using data on the risk or prevalence of fracture in 
adults  with  comparison  to  their  birth  and/or  early  life  records  (as  surrogate  markers  of  early  life 
nutrition and stresses); (2) mother-offspring cohorts in which the nutrition, body build and lifestyles of 
women  before  and  during  pregnancy  were  explored  in  relation  to  bone  mass  in  their  offspring;  
(3) detailed physiological studies that have explored candidate endocrine systems and age-related bone 
loss;  (4)  evidence  of  phenotypic  responses  to  changes  in  environment  from  the  natural  world;  
(5) animal studies showing epigenetic modifications in response to controlled changes in environment, 
and  finally  emerging  work  concerning  epigenetic  changes  associated with  pathways  that influence 
skeletal health in humans. Whilst discussing these groups of studies we will explore theories about the 
basis of such interactions. 
 
3. Maternal Behavior and Bone Development 
 
3.1. Retrospective Cohort Studies 
 
The first evidence of a link between early life and osteoporosis risk came from an epidemiological 
study of 21-year-old women born in Bath from 1968 to 1969 [20]. Independent of adult weight and 
body mass index there was a statistically significant relationship between the girl‘s weight at 1 year old 
and their adult BMC at the lumbar spine and femoral neck, important sites of osteoporotic fracture.  
In the Hertfordshire cohort study the relationship between weight at 1 year and adult BMC remained 
when the subjects reached the age of 60–75 years, and was present in both sexes [21]. Using health 
visitor records the authors found a positive association between weight at 1 year and adult bone area at 
the spine and hip (p < 0.005). The relationships remained after adjustment for known genetic markers 
of osteoporosis risk, such as polymorphisms in the gene for the vitamin D receptor (VDR), and after 
adjustment for lifestyle characteristics in adulthood that might have influenced bone mass (physical 
activity,  dietary  calcium  intake,  cigarette  smoking,  and  alcohol  consumption).  These  findings 
corroborate  observations  from  studies  performed  in  United  States,  Australia,  Sweden  and  the 
Netherlands [22]. 
Further analysis of the DXA scan images of the participants from the Hertfordshire cohort study 
showed a positive relationship between weight at 1 year and the inter-trochanteric width of the femur, 
but not femoral neck length [23]. The association remained after adjustment for adult body weight and 
was independent of proximal femoral BMC. This suggests that poor growth in utero and during the 
first  year  of  life  is  associated  with  disproportion  of  the  proximal  femur  in  later  life  leading  to  a Int. J. Environ. Res. Public Health 2010, 7                 
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narrower neck but preserved axis length. This would correspond to a reduction in the mechanical 
strength of the region, over and above that attributable to BMC alone.  
Twin  studies  provide  an  ideal  opportunity  for  looking  at  the  effect  of  the  environment  upon 
development whilst controlling for genetic variation [24]. In a study of 445 monozygotic (MZ) and 966 
dizygotic (DZ) twins from the UK, at a mean age of 47 years, birth weight was found to positively 
predict BMC and BMD [25]. The MZ twins, despite being genetically identical, had greater intra-pair 
variability  in  birth  weight  than  DZ  twins.  This  highlights  the  crucial  role  of  the  intrauterine 
environment in development, as two-thirds of the MZ twins will have shared a placenta, whereas all 
the DZ twins will have had a placenta each. A majority of the MZ twins therefore had to compete for 
placental resources, with a subsequent compromise in their genetic growth potential. Furthermore, in 
the MZ twins compared to the DZ twins there was a stronger intra-pair association between birth 
weight and bone density. This is despite the MZ twins having the same genetic growth potential, and 
the DZ twins having differing genetic make-ups, which would act to widen the variability in their 
growth. This suggests that the early adverse environment of the smaller MZ twin, when competing for 
the resources of one placenta, strongly influenced the fetus‘s future adult skeletal status.  
It has now been shown that growth in utero and early life is associated with the actual risk of 
fracture, using data from the Helsinki Cohort Study [26]. Birth and childhood growth data from 7,000 
men  and  women  born  in  Helsinki  University  Central  Hospital  during  1924–1933  were  linked  to 
hospital  discharge  records  for  hip  fracture  (n  =  112).  After  adjustment  for  age  and  gender  three 
independent  determinants  of  hip  fracture  risk  were  identified:  tall  maternal  stature  (p  <  0.001), 
shortness at birth (p = 0.03) and low rate of childhood growth (height p = 0.006, weight = 0.01). 
Additionally, people who had hip fractures were more likely to be shorter at birth but of average height 
by age 7 years. This suggested that hip fracture risk may be particularly elevated among children in 
whom the growth of the skeletal envelope had been forced ahead of its capacity to mineralize. This 
could indicate a disadvantage of a mismatch between intrauterine and early life environments, with 
influences from both areas upon the eventual phenotype. 
3.2. Mother-Offspring Studies and Developmental Origins of Health and Disease 
There is a strong biological basis for a model of disease pathogenesis in which a single genotype can 
give  rise  to  several  different  phenotypes,  allowing  the  organism  to  adapt  future  generations  to 
prevailing  environmental  conditions.  This  phenomenon  is  termed  developmental  plasticity  [27]. 
Experimentalists  have repeatedly demonstrated that alterations to the diet of pregnant animals can 
produce lasting changes in the offspring‘s physiology and metabolism [28]. In humans the importance 
of  the  intrauterine  environment  was  initially  demonstrated  by  showing  the  increased  risk  of 
hypertension, coronary heart disease and diabetes with being at the lower end of normal compared to 
the upper end of normal birth weight [29-31]. The cohort studies above suggest a similar effect for the 
risk of osteoporosis.  
The  ―thrifty  phenotype‖  model  suggests  that  the  fetus  becomes  growth  retarded  in  response  to 
adverse environmental conditions in utero, and the associated adaptations induce a phenotype better 
suited to a deprived post natal environment [32]. This could be understood as a focus of resources on 
surviving early life, with a consequent diversion away from the functions of repair and protect. A Int. J. Environ. Res. Public Health 2010, 7                 
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striking example of the thrifty phenotype preparing undernourished fetuses for a harsh environment 
came from an Ethiopian famine exposed population, in which control children had a 9 times lower 
incidence of rickets than children with high birth weights [33]. This suggested that infants who had a 
harsh intrauterine environment were better able to cope with postnatal nutritional deprivation. The later 
life  cost  of  neonatal  adversity  inducing  a  ―thrifty‖  interaction  with  the  environment  has  been 
investigated in a cohort born during the Dutch famine winter of 1944–45. As the cohort has advanced 
into middle age they have been shown to  have higher rates a diverse range of diseases including 
coronary heart disease, diabetes, breast cancer and schizophrenia [34,35]. 
However, the thrifty phenotype model does not easily account for the graded effect on the risk of 
diseases,  such  as  osteoporosis,  seen  across  the  range  of  normal  birth  weight,  and  in  non-extreme 
conditions.  The  ‗developmental  origins‘  hypothesis  extends  the  ―thrifty  phenotype  hypothesis‖  to 
propose that an altered long-term risk of disease is the result of adaptive responses that the fetus or 
infant makes to cues from the mother about her health or physical status [36]. In this way small size at 
birth is not seen as causing a greater risk of osteoporosis, but rather both are outcomes of an adaptive 
response to a more difficult intrauterine environment [37]. 
The developmental origins hypothesis describes predictive adaptive responses being made at the 
phase  of  developmental  plasticity  (such  as  during  intrauterine  life,  possibly  during  the  ―critical 
period‖),  to  optimize  the  phenotype  for  the  probable  environment  of  the  mature  organism  [27].  
Mother-offspring cohorts provide an ideal opportunity to assess such interactions.  
The first mother-offspring cohorts measured parents‘ anthropometric and lifestyle characteristics 
and related this to their child‘s neonatal bone mass [38]. After adjustment for gestational age and 
gender, neonatal bone mass was strongly positively associated with birth weight, birth length, and 
placental weight. Maternal triceps skinfold thickness at 28 weeks positively correlated with neonatal 
BMD, and mothers who smoked in pregnancy had, on average, babies with an 11% lower whole body 
BMC than mothers who did not smoke. Interestingly smoking at the time of the last menstrual period 
was  not  associated  with  neonatal  BMC  or  BMD,  suggesting  a  fundamental  importance  of  the 
immediate intrauterine environment.  
The  Southampton  Women‘s  Survey  provided  the  opportunity  to  further  investigate  these 
interactions  in  a larger sample of 841 infants  [39]. This  confirmed that independent  predictors of 
greater neonatal whole body bone area and BMC included greater maternal birthweight, height, parity, 
fat stores (triceps skinfold thickness), and lower physical activity in late pregnancy. Maternal smoking 
was again statistically significantly (and independently) associated with lower neonatal bone mass. 
These relationships were observed in both male and female neonates. 
 
3.3. Physiological Studies 
 
Nutrition 
 
The mother-offspring cohorts also provide a platform to investigate the mechanism of interactions 
between maternal behavior and later bone health. Calcium and vitamin D, being key nutrients in the 
process of bone formation, are prime candidates for investigation. In the study of children involved in 
the nutrition in pregnancy study, bone mass in childhood was positively associated with  corrected Int. J. Environ. Res. Public Health 2010, 7                 
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calcium level in the umbilical cord of the child at birth (r = 0.19, p = 0.02) [40]. In this study 31% of 
the mothers had insufficient and 18% had deficient circulating concentrations of 25(OH) vitamin D 
during late pregnancy (11–20 and <11 g/L respectively). Lower concentrations of serum 25(OH) 
vitamin D in mothers during late pregnancy were also associated with reduced whole-body and lumbar 
spine BMC in children at age 9 years [40]. Maternal vitamin D status was statistically significantly 
associated with childhood bone area, and areal BMD. Estimated exposure to ultraviolet B radiation 
during late pregnancy (p < 0.0001) and the maternal use of vitamin D supplements (p = 0.01) both 
predicted maternal 25(OH) vitamin D concentration, and childhood bone mass (p = 0.03). Additional 
evidence supporting a role for maternal vitamin D status was obtained in the Southampton Women‘s 
Survey, when maternal vitamin D concentrations again correlated with neonatal bone mass [41]. In 
developing populations, often the nutrient in short supply is calcium rather than vitamin D: Children of 
mothers, in a mother-offspring cohort study in Pune, India [42], who had a higher frequency of intake 
of  calcium-rich  foods during pregnancy had higher total  and lumbar spine BMC and areal  BMD, 
independent  of  parental  size  and  bone  composition.  Circulating  maternal  25(OH)  vitamin  D 
concentrations  in  this  cohort  were  relatively  high,  and  were  not  associated  with  childhood  
skeletal measures.  
Studies of maternal nutrition have also been able to look beyond maternal calcium homeostasis to 
the broader relationship between maternal dietary pattern and childhood bone mass. In a Southampton 
cohort, principal component analysis was used to identify a pattern of dietary intake characterized by 
high intakes of fruit, vegetables, wholemeal bread, rice and pasta, and low intakes of confectionary, 
added sugar, white bread and crisps [43,44]. As this matched national guidance on health eating it was 
termed the ―prudent diet‖. Greater compliance with this ―healthy‖ dietary pattern during pregnancy was 
associated with increased offspring whole body and lumbar spine BMD at age 9 years (p < 0.001), 
independent of maternal body build, smoking and physical activity [45]. 
It therefore appears that maternal diet during pregnancy is likely to have an effect on her offspring‘s 
bone  development.  The  question  then  arises  as  to  whether  this  is  a  direct  effect  of  the  nutrients 
available  for  bone  development,  or  mediated  via  an  alternative  pathway,  and  what  other  factors 
influence such pathways. 
Endocrine Signaling 
As described earlier the Growth Hormone–Insulin like Growth Factor 1 (GH-IGF-1) pathway is 
known to be involved in bone development. Cortisol, an endogenous glucocorticoid, influences the 
GH-IGF-1 pathway, as well as itself being skeletally active [45]. Physiological studies of hypopituitary 
patients indicate that low levels of growth hormone increase the risk of osteoporotic fracture [46], and 
exogenous glucocorticoids are well known to increase the risk of osteoporosis. 
Developing chondrocytes have been found to express IGF-1 mRNA, and IGF-1 has been shown to 
stimulate their proliferation [47]. The placenta acts as a barrier between the maternal and fetal IGF 
systems,  with  fetal  IGF  predominantly  produced  in  the  fetal  liver.  Javaid  et  al.  [48]  found  that 
umbilical cord serum IGF-1 concentration positively correlated with neonatal whole body BMC, BMD, 
lean mass and fat mass. Cord serum IGF-1 levels partly explained the effect of maternal smoking upon 
offspring skeletal development, but did not account for the other previously demonstrated parental Int. J. Environ. Res. Public Health 2010, 7                 
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characteristics, such as height, weight and fat mass. This suggested that both IGF-1 dependent and 
independent factors influence bone parameters of the neonate. 
In adults profiles of circulating GH and cortisol were compared to bone density and birth records of 
patients  in  the  Hertfordshire  cohort  study  [49-51].  It  was  found  that  weight  at  1  year  positively 
correlated with median GH concentration and negatively correlated with cortisol concentration at age 
61–72 years, suggesting a ―memory‖ of a difficult intrauterine or early life environment. Furthermore 
the profiles of these two hormones were found to be determinants of prospectively determined bone 
loss rate, suggesting a physiological outcome of this ―memory‖. This suggests that the GH-IGF axis is 
instrumental in both the formation and maintenance of skeletal health, additionally the ability of this 
system to maintain skeletal health may be influenced by the events of intrauterine life.  
Genetic variation 
In order to dissect the relationship between fixed genetic variations in key genes, growth in infancy 
and adult skeletal bone health, studies are now assessing single nucleotide polymorphisms with these 
parameters.  When  looking  at  the  growth  hormone  gene  (GH1)  it  was  found  that  homozygotes  at 
specific  loci  (A5157G  and  T6331A)  displayed  lower  BMD  and  had  an  accelerated  rate  of  bone  
loss  [52].  Interestingly,  there  was  also  a  statistically  significant  (p  =  0.04)  interaction  with  GH1 
genotype, weight at 1 year and rate of bone loss, suggesting susceptibility in the GH/IGF-1 pathway to 
alterations by environmental influences during intrauterine and early postnatal life.  
A further example of a dynamic interaction between genetic and environmental influences of bone 
mass  was  shown  in  the  analysis  of  the  vitamin  D  receptor  (VDR)  genotype  and  adult  BMD  in 
participants of the Hertfordshire cohort study. There was no significant association between the either 
birth weight or VDR and adult BMD in the cohort as a whole [53]. However the relationship between 
lumbar spine BMD and VDR varied according to birth weight. After adjusting for age, gender and 
weight at baseline it was shown that individuals in the lowest third for birth weight had a higher spine 
BMD if they were of the BB genotype (p = 0.01). People of the same genotype who were in the highest 
third for birth weight had a lower spine BMD compared to subjects in the same birth weight category 
(p = 0.04). This suggests that genetic influences on adult bone size might be modified by nutrition 
in utero. 
In summary maternal behavior, in the form of activities such as smoking, dietary choices including 
calcium and vitamin D intake, and alterations in the endocrine pathways especially in early life, have 
been shown to correlate with offspring bone health [48,50,54,55]. The extent to which a particular 
environment influences the phenotype may depend upon the genotype of that individual [52,53] and 
the interaction between gene and environment. 
3.4. Developmental Plasticity in the Natural World 
There  are  striking  examples  of  particular  hormones,  nutrition  and  environmental  states,  during 
sensitive periods of early life, permanently programming the structure and physiology of non-human 
animals. The African army worm moth (Spodoptera exempta) is an example: as a caterpillar if it grows 
in an overcrowded, undernourished environment it develops into a moth with a metabolism that mainly 
uses fatty acids. The fatty acids give energy for long-distance flight, so the moth is better adapted to Int. J. Environ. Res. Public Health 2010, 7                 
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seek a less crowded environment. If the caterpillar grows in a more hospitable environment then it has 
a metabolism which is more efficient when staying in the area [56]. In mammals it has been shown that 
the thickness of the meadow vole‘s coat is determined by the amount of light the mother is exposed to 
prenatally [57]. In this way the vole offspring is better able to adapt for the season it will be born into. 
The underlying mechanism of the observed variations in phenotype secondary to the experienced early 
life  environment,  both  in  the  natural  world  and  in  humans,  is  thought  to  involve  
epigenetic mechanisms. 
3.5. Epigenetics in Animal and Human Studies 
Epigenetics refers to changes in phenotype or gene expression caused by mechanisms other than 
changes in the underlying DNA sequence [58]; each cell in the body acquires a unique ―epigenetic 
signature‖  reflecting  the  genotype,  developmental  history  and  environmental  influences  upon  the  
cell [59]. These changes then influence cell function, and so the phenotype of the organism. The two 
most  studied  forms  of  epigenetic  marking  are  DNA  methylation  and  histone  modification.  DNA 
methylation involves the addition of a methyl group to cytosine residues at the carbon-5 position of 
CpG dinucleotides. DNA methylation is generally associated with gene repression, either by decreased 
binding of transcription factors or by attracting methyl-CpG-binding proteins that act as transcriptional 
repressors [60,61].  
In rats it has been shown that protein restriction during pregnancy is associated with a decrease in 
the  methylation  of  the  glucocorticoid  receptor  promotor,  and  a  corresponding  increase  in  the 
expression of the glucocorticoid receptor [62,63]. An effect of this could be an increased sensitivity of 
osteoblasts to cortisol, which may act to decrease bone mineral density. This would be consistent with 
the findings of a positive association between birth weight and basal levels of cortisol [49], and the 
negative association between integrated cortisol concentration and bone density in adults from the 
Hertfordshire cohort study [50]. Thus the glucocorticoid axis presents an alternative pathway linking 
maternal nutrition to offspring bone mass.  
4. Future Work 
The role of the early life environment has been shown to have far reaching health consequences in 
the life of the child, including a significant impact upon their skeletal development. This supports the 
general need for a programme of interventional research aimed at improving general dietary quality 
among  women  before  conception  and  during  pregnancy,  in  addition  to  studies  that  evaluate  the 
targeting of specific micronutrients such as vitamin D and calcium. 
The Maternal Vitamin D in Osteoporosis Study (MAVIDOS) is a randomized controlled trial to 
investigate  whether  supplementation  of  vitamin  D  during  pregnancy  serves  to  optimize  offspring 
skeletal development, and commenced recruitment in 2008. The study aims to test the hypothesis that 
vitamin  D  supplementation  of  pregnant  women  who  have  low  levels  of  vitamin  D  will  result  in 
improved neonatal bone mineral content. This is an ideal platform on which to investigate epigenetic 
modulation of placental calcium transport, particularly the role of vitamin D. This should improve our 
understanding of the processes involved in developing osteoporosis, and potentially provide a focus for 
interventions to avert detrimental processes by influencing maternal dietary habits. Int. J. Environ. Res. Public Health 2010, 7                 
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5. Conclusion 
Osteoporosis  is  a  major  cause  of  morbidity  and  mortality  through  its  association  with  fragility 
fractures. It is becoming increasingly clear that there is a relationship between growth and development 
in early life and bone health in older age. Sub optimal bone development leads to a reduction in peak 
bone mass, and a higher risk of osteoporotic fracture in later life. Epigenetic processes may be the 
mechanism  by  which  the  ―memory‖  of  early  life  environment  in  stored  in  the  offspring.  Future 
understanding of the mechanisms by which maternal diet and behavior influence offspring skeletal 
development may suggest focused interventions to improve skeletal health throughout the life course, 
and reduce the burden of osteoporotic fracture in future generations.  
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